by James Rudge, PhD, Technical Director, Neoteryx | 6 min read
An article by Marianne Fillet et al at University of Liège in Belgium was published in the May 2021 edition of Frontiers in Molecular Biosciences. It reported on a proof-of-concept …
Read Storyby Neoteryx | 7 min read
The media frenzy surrounding the 2021 fraud trial of Elizabeth Holmes, the disgraced founder and CEO of blood-testing startup Theranos, has drawn the world’s attention. The Theranos story will gain …
Read Storyby Neoteryx | 4 min read
Capillary blood sampling was first developed to extract blood samples from newborns and infants whose veins were too small for venous blood draws. The "heel stick" approach to collecting capillary …
Read Storyby Neoteryx | 1 min read
When Fasha Mahjoor launched Neoteryx, he planned to change the way dried capillary blood is collected, to become the most significant blood microsampling innovator in the modern marketplace. In that, …
Read Storyby Neoteryx | 2 min read
Capillary blood microsampling is a simple procedure that allows participants to draw their own blood in small, precise, useful amounts. This makes it easy to collect samples anywhere, which opens …
Read Storyby Neoteryx | 1 min read
Venipuncture is painful. It's frightening. When you're performing research with vulnerable patient populations, it can pose a significant impediment to recruiting and retaining study volunteers. Traditional blood draws are particularly …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.